Skip to content

Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP

Prospective, Randomized, Three-arm, Open Controlled Trial Comparing the Quality of Micturition and the Patient Comfort by Various Urinary Drainage After Robot-assisted Radical Prostatectomy (RARP)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02812173
Acronym
MPH
Enrollment
234
Registered
2016-06-24
Start date
2016-05-31
Completion date
2018-06-30
Last updated
2022-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

urinary drainage, urethral catheter, suprapubic tube, pain, discomfort, radical prostatectomy, robotic surgery, urinary infection

Brief summary

The purpose of the study is to determine, whether the postoperative quality of micturition and continence can be improved depending on the urinary drainage catheter and retention after robot assisted radical prostatectomy. Another finding could be the study of the pain assessment of the patient, as well as the pain medication at the various derivatives. Further check whether infections and the presence of bacteriuria can be reduced or avoided by the form of urinary drainage.

Interventions

DEVICEsuprapubic tube ex 2 day

balloon catheter for suprapubic bladder-drainage, suprapubic tube removal on the second day after the surgery

DEVICEsuprapubic tube ex 5 day

balloon catheter for suprapubic bladder-drainage, suprapubic tube removal on the fifth day after the surgery

DEVICEtransurethral catheter ex 5 day

transurethral catheter withdrawal removal on the fifth day after the surgery

Sponsors

St. Antonius Hospital Gronau
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Minimum age of 18 Years * Voluntarily agreement to participate in this study * filled in and signed Informed Consent * release of medical records for regulatory or research purposes * clinically organ-confined prostate cancer * recommended and planned robot-assisted radical prostatectomy

Exclusion criteria

* Participation in other interventional trials that could interfere with the present study * International Prostate Symptom Score (IPPS) \> 18 * History of radiation or chemotherapy * History of transurethral prostate resection * unable to provide informed consent * unwillingness to storage and forwarding of pseudonymous data

Design outcomes

Primary

MeasureTime frame
Urinary leakage measured by pad test in gramswithin the day 2 or day 5 after the surgery for 24 hours

Secondary

MeasureTime frame
Detection of postoperative pain related to urinary drainage by numeric rating scale (NRS)once a day, first 7 days after the surgery
Recording of complicationswithin the 4 weeks after surgery
Urine status measured by flow cytometrywithin the day 2 or day 5 after the surgery
Residual urine measured by bladder scan in ml3 times within the day 2 or day 5 after the surgery

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026